This is an example of the report a Noverix Verify client receives. All details below are illustrative only — they do not describe a real product or lot.
SAMPLE
NOVERIX VERIFY · VERIFICATION REPORT
COA & Lot Verification
Report NVX-VR-2026-0148 · Issued June 2026 · Research-use-only material
Findings
Testing laboratory named & independently identifiablePASS
HPLC purity method present and consistent (99.1% main peak)PASS
LC-MS identity confirmation providedNOT PROVIDED
Molecular weight verified against the compoundN/A — no MS data
Lot number and test date present & traceable to a batchPASS
Template / reused-certificate indicatorsNONE DETECTED
Risk assessment
MODERATE
Purity is well-documented and traceable, but identity is not independently confirmed by mass spectrometry — a sample can be 99% pure and still be the wrong molecule.
Recommendation. The HPLC purity documentation is internally consistent and traceable to a specific lot. However, identity is not confirmed by LC-MS. Before relying on this lot, obtain independent confirmatory LC-MS identity testing. Noverix Verify can coordinate this with an accredited third-party laboratory and reissue an updated report.
Reviewed by a Noverix analyst — background in analytical, microbiology, and R&D laboratories at AbbVie, Bristol Myers Squibb, and Thermo Fisher Scientific; trained on HPLC/LC-MS and analytical-data review.
This sample is for illustration only and does not describe a real product or lot. A Noverix Verify report reflects a professional review of analytical documentation against quality criteria and is not a guarantee of identity, purity, safety, or fitness for any purpose. Noverix does not sell peptides for human use and does not provide medical, dosing, or clinical guidance. Research-use-only.